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The Bay of Bengal is known as the epicenter for seeding several
devastating cholera outbreaks across the globe. Vibrio cholerae, the
etiological agent of cholera, has extraordinary competency to ac-
quire exogenous DNA by horizontal gene transfer (HGT) and adapt
them into its genome for structuring metabolic processes, develop-
ing drug resistance, and colonizing the human intestine. Antimicro-
bial resistance (AMR) in V. cholerae has become a global concern.
However, little is known about the identity of the resistance traits,
source of AMR genes, acquisition process, and stability of the ge-
netic elements linked with resistance genes in V. cholerae. Here we
present details of AMR profiles of 443 V. cholerae strains isolated
from the stool samples of diarrheal patients from two regions of
India. We sequenced the whole genome of multidrug-resistant
(MDR) and extensively drug-resistant (XDR) V. cholerae to identify
AMR genes and genomic elements that harbor the resistance traits.
Our genomic findings were further confirmed by proteome analy-
sis. We also engineered the genome of V. cholerae to monitor the
importance of the autonomously replicating plasmid and core ge-
nome in the resistance profile. Our findings provided insights into
the genomes of recent cholera isolates and identified several ac-
quired traits including plasmids, transposons, integrative conjuga-
tive elements (ICEs), pathogenicity islands (PIs), prophages, and
gene cassettes that confer fitness to the pathogen. The knowledge
generated from this study would help in better understanding of V.
cholerae evolution and management of cholera disease by provid-
ing clinical guidance on preferred treatment regimens.
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Cholera is an acute secretory diarrheal disease caused by theVibrio cholerae, a Gram-negative comma-shaped bacterium
that infects humans through contaminated water or food. It is
still a major public health burden in many developing countries,
including India (1). The pathogen has extraordinary competency
to acquire exogenous DNA through horizontal gene transfer
(HGT) and adapt them into its genome for structuring metabolic
processes, developing drug resistance, colonizing the human in-
testine, and producing cholera toxin (2, 3).
Although administration of oral or i.v. rehydration solution
containing glucose, sodium chloride, potassium chloride, and tri-
sodium citrate is the major choice for the treatment of cholera,
antibiotics are also used to reduce stool volume and duration of
diarrhea (4). Antimicrobial resistance (AMR) in V. cholerae is
becoming increasingly common across the globe (5). Emergence of
antibiotic resistance in bacteria is a natural phenomenon, wherein
the indiscriminate usage of antibiotics in healthcare, livestock, and
agriculture endorses the resistant variants to flourish in the eco-
system (6, 7). Several mechanisms such as efflux pumps, reduced
permeability, alternative metabolic pathways, target modifications,
enzymatic inactivation of antimicrobials, and so forth can confer
antibiotic resistance in bacterial species (8). Many of the antibiotic
resistance genes are physically linked with mobile genetic elements
(MGEs) and disseminate to closely or distantly related bacterial
species by lateral and vertical gene transfer (9, 10). The genes that
encode resistance function and the genetic elements that carry the
resistance genes widely vary depending upon the type of pathogen
and their geographic locations (11). In India, despite the alarming
increase in the prevalence of resistant pathogens, only limited in-
formation is available about the current scenario of AMR in V.
cholerae isolates and the genetic identity of resistance traits (6).
In this study, we have analyzed the antibiotic susceptibility of
443 V. cholerae strains isolated during 2008 to 2015 from two
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centers in India, one in a diarrheal disease-endemic area, Kolkata
(east India), and the other in a diarrheal disease-nonendemic
area, Delhi (north India). We investigated the genome sequences
of multidrug-resistant (MDR) and extensively drug-resistant
(XDR) V. cholerae isolates to identify AMR genes and the
MGEs that are physically linked with resistance genes. We report
here the presence of blaNDM-1, which encodes New Delhi
metallo-beta-lactamase-1 in the chromosome of V. cholerae isolated
from the stool samples of diarrheal patients. Earlier blaNDM-1
was isolated only from septicemia patients. We further provide
insights about the molecular identity of different AMR traits and
the MGEs that carry resistance-associated genes in the genome of
V. cholerae. In addition, we report the presence of multiple resis-
tance genes against the same antibiotics in individual isolates. We
engineered the genome of XDR V. cholerae strains to explore the
contribution of autonomously replicating extrachromosomal ge-
netic elements to antimicrobial resistance. Finally, we investigated
the whole-cell proteome of XDR V. cholerae isolate to explore the
expression of resistance genes in the presence and absence of
antibiotics. Our findings provide insights into the genomes of drug-
resistant cholera pathogens, functionality of resistance genes,
expression of AMR genes, and mobile nature of genetic elements
linked with resistance- and fitness-encoding functions.
Results
Antimicrobial Resistance Profile of V. cholerae Isolated During 2008
to 2015. Natural isolates of V. cholerae can be intrinsically re-
sistant to a few antibiotics. Most of the resistance traits in V.
cholerae are acquired via spontaneous mutations in the target genes
or by HGT. For a better understanding of acquired resistance
traits in O1 and serogroups of V. cholerae isolates other than O1
and O139 (called nonO1-nonO139), we selected 22 antibiotics
belonging to nine different classes that interact and interrupt
cellular pathways involved in cell-wall biosynthesis, DNA, RNA,
and protein syntheses, and metabolic processes. For all of the
isolates, the number of antibiotics against which the resistance was
observed is reported in Dataset S1. Overall, the resistance di-
versity of V. choleraeO1 is higher compared with nonO1-nonO139
isolates (Fig. 1). Based on the resistance profile, V. cholerae isolates
could be clustered into three groups: (i) sensitive, (ii) multidrug-
resistant (>2 but <10), and (iii) extensively drug-resistant (>10)
isolates. Almost 99% of V. cholerae isolates (n = 438) are resistant
against≥2 antibiotics, 17.2% isolates (n= 76) are resistant against≥10
antibiotics, and 7.5% isolates (n = 33) are resistant against ≥14
antibiotics. The highest resistance was detected against sulfame-
thaxozole (99.8%, n = 442), the antibiotic that inactivates bacterial
dihydropteroate synthase (Fig. 2). In addition, resistance to nalidixic
acid (n = 429), trimethoprim (n = 421), and streptomycin (n = 409)
are also very high in V. cholerae isolated from both centers (Fig. 2).
Among all of the selected antibiotics, resistance to neomycin was
observed to be lowest (4.0%, n = 18) (Fig. 2). Resistance diversity
(RD) of V. cholerae strains isolated from Kolkata (average RD 7.36;
SD 3.1) is significantly higher compared with those from Delhi
(average RD 6.07; SD 2.32). However, it is important to note that
all of the V. cholerae strains (n = 317) of Kolkata origin were iso-
lated during 2014 and 2015, while Delhi origin isolates (n = 126)
were collected during 2008 to 2013. The years of isolation may also
influence the resistance diversity of the isolates.
Differential Detection of Antibiotic Resistance. The variation in the
resistance diversity of V. cholerae O1 (n = 412) and nonO1-
nonO139 (n = 31) strains isolated during 2008 to 2015 was
also determined (Fig. 3). While resistance to streptomycin, tri-
methoprim, nalidixic acid, tetracycline, and chloramphenicol are
significantly higher in O1 isolates, resistance to polymixin B, ri-
fampicin, and erythromycin were observed to be higher in
nonO1-nonO139 isolates. The trend of resistance over the years
to various antibiotics was observed to have specific patterns for
some antibiotics (Fig. 4). While the resistance to tetracycline
progressively decreased from 2008 to 2014, an increasing re-
sistance trend was observed for imipenem and spectinomycin
(Fig. 4). Since most of the V. cholerae strains were isolated from
Kolkata during 2014 (n = 148) and 2015 (n = 168), we compared
the resistance trends during this period. The resistance to spec-
tinomycin, rifampicin, and ciprofloxacin increased in 2015, while
resistance to chloramphenicol and polymixin B decreased (Fig.
4). The resistance against imipenem and neomycin was very low
compared with other antibiotics. Overall, resistance against most
of the antibiotics, except polymixin B and tetracycline, increased
significantly post 2011 (SI Appendix, Fig. S1).
Genomics of V. cholerae-Resistant Isolates.We have sequenced and
analyzed the whole genomes of four V. cholerae isolates belonging
to O1, O139, and nonO1-nonO139 serotypes that showed different
resistance profiles (SI Appendix, Fig. S2). All V. cholerae isolates
harbored two nonhomologous, circular chromosomes (Chr1 and
Chr2) containing close to 4,000 ORFs. Nearly 5% of the genomes
Fig. 1. (A) Antimicrobial resistance diversity in V. cholerae isolates. (B) Number
of antibiotics against which resistance was detected. The V. cholerae strains were
isolated during 2008 to 2015. (C) The resistance diversities showed significant vari-
ations between isolates belonging to different serotypes. Lines extending vertically
from the boxes in B and C showing variability outside the upper and lower quartiles.
Fig. 2. Resistance profile of V. cholerae against different antibiotics. Bar
graph showing the number of isolates in which resistance was detected against
different antibiotics. The highest number of isolates showed resistance to
sulfamethoxazole. Minimum resistance was detected against neomycin.
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of resistant V. cholerae isolates sequenced in the present study
contained different MGEs including pathogenicity islands (PIs),
metabolic islands, prophages, plasmids, and transposons that have
been acquired by HGT from closely or distantly related bacterial
species (Table 1). Integration of most of these MGEs in V. cholerae
chromosomes is reversible, and can be excised and propagated to
other V. cholerae cells. Comparative genomics of four isolates
revealed close similarity between IDH08148 and IDH0046 (Table 2).
Both VCE232 and IDH06781 belong to the nonO1-nonO139
serogroup, but the homology of VCE232 genome sequences is
higher with the genome sequences of the O1 (IDH08148) and O139
(IDH0046) serogroups. However, the VCE232 genome has no
plasmid, but the genome of IDH08148 harbors one autono-
mously replicating plasmid.
Most of the resistance can be due to the absence of susceptible
target (intrinsic) or acquired functions through HGT. For a
better picture of AMR traits in V. cholerae strains isolated from
India, we did whole-genome sequencing and analysis of the ge-
nomes of two XDR and two MDR V. cholerae isolates belonging
to the O96, O1, O139, and O4 serogroups, respectively (SI Ap-
pendix, Fig. S2). The whole-genome sequences of all of the iso-
lates were made by pyrosequencing (454 GS FLX+), and the
sequences of all of the isolates were deposited in the National
Center for Biotechnology Information (NCBI) database. Relevant
sequencing information and strain characteristics are reported in
Table 1. All of the drug-resistant V. cholerae have a plastic bipartite
genome equipped with several MGEs that encode antibiotic
resistance, toxins, virulence factors, and metabolic enzymes (SI
Appendix, Fig. S2). Our analysis of the genome sequences of all
of the four resistant isolates identified more than 40 AMR genes
that encode resistance against β-lactams, aminoglycosides, macro-
lides, tetracyclines, fluoroquinolones, bleomycin, and bicyclomycin
antimicrobials (Fig. 5). The highest numbers of resistance genes
were detected against aminoglycosides. Similarly, we have identi-
fied multiple β-lactamase genes representing four classes (A, B, C,
and D) of the Ambler classification scheme in the genome of each
isolate. The genomes of XDR V. cholerae isolates IDH06781 and
IDH08148 harbor eight and seven different β-lactamase–encoding
genes, respectively (Fig. 5). Similar resistance genes were also
present in the genomes of ESKAPE pathogens (SI Appendix,
Table S1). By analyzing the immediate genetic vicinity of the
blaNDM-1 gene of IDH06781 and IDH08148, we observed that
the bleomycin resistance-encoding sh ble gene is physically linked
with the blaNDM-1 gene. Further analysis of the genomic scaffolds
of these isolates revealed that the sh ble and blaNDM-1 genes are
coexpressed under the control of the same promoter, located up-
stream of the blaNDM-1 gene and at the extremity of the insertion
sequence ISAba125 (Fig. 6). Phenotypically, both isolates showed
resistance against imipenem and zeocin, and the traits are functional
in heterologous genetic backgrounds, including Escherichia coli
(SI Appendix, Table S2). Plasmid-curing experiments provided
convincing evidence that the ISAba125 element linked with the
sh ble and blaNDM-1 genes are located on the chromosome of the
V. cholerae IDH06781 isolate (SI Appendix, Table S3). Previously,
blaNDM-1–positive nonO1-nonO139 V. cholerae was identified
from a septicemia patient (12). This study reports the chromo-
somal integration of blaNDM-1 in a V. cholerae genome isolated
from diarrheal patients. It is important to note that blaNDM-1–
encoded metallo-beta-lactamase confers resistance against various
beta-lactam antibiotics, including imipenem. The genomes of IDH0046
and VCE232 do not encode any β-lactamase–encoding genes.
Other than β-lactamase, IDH06781, IDH08148, and IDH0046
genomes harbor multiple genes (aph, aac, and ant) that confer
resistance against several aminoglycoside antibiotics (Fig. 5).
In addition, genomes of all of the isolates are enriched with genes
for aminoglycoside protection protein, tetracycline efflux pumps,
and tetracycline-modifying functions (Dataset S2). Further analysis
of resistance genes and their translated proteins using publicly available
Antibiotic Resistance Genes Database, Comprehensive Antibiotic
Resistance Database (CARD), and The Protein Data Bank data-
bases revealed the presence of similar AMR genes in the genomes
of other enteric pathogens, including Klebsiella pneumoniae, en-
teropathogenic E. coli, Salmonella enterica, Shigella sp., and so forth.
Functional Evaluation of Resistance Traits. Several in silico studies
have revealed a plethora of commensals, symbionts, and op-
portunistic pathogens inhabiting the human gastrointestinal tract
housing hundreds of AMR genes in their genomes (10, 13). The
functions of AMR genes were predicted by comparing sequence
homology to the genes that have been cataloged as AMR genes in
the databases. Therefore, to rule out possible false-positive anno-
tation, we validated the functions of most of the resistance genes
that contribute to the resistance phenotype of the IDH06781 iso-
late. We amplified 16 different genes from the genome of XDR
isolate IDH06781, cloned them into expression vectors pBD62 or
pBAD24, and determined their resistance function in heterologous
genetic backgrounds (SI Appendix, Table S2). Most of the bla genes
selected for functional evaluation confirmed resistance against
reported minimum inhibitory concentration of the respective an-
tibiotic in heterologous host E. coli (SI Appendix, Table S2). We
also observed that blaNDM-1 inactivates all of the tested β-lactam
antibiotics, except aztreonam. As expected, the activity of the
blaNDM-1–encoded enzyme was completely inhibited in the pres-
ence of the metal ion chelator EDTA (SI Appendix, Table S2).
Antibiotic Resistance Genes Are Linked with Mobile Genetic Elements.
The genomic elements contributing to the carriage and dissem-
ination of resistance traits and emergence of MDR and XDR
Fig. 3. Differential resistance pattern between V. cholerae O1 and V. cholerae
nonO1-nonO139 clinical isolates. Resistance is high in O1 isolates against tet-
racycline, chloramphenicol, streptomycin, and trimethoprim. NonO1-nonO139
isolates showed higher resistance to polymixin B compared with O1 isolates.
Fig. 4. Yearwise resistance pattern of V. cholerae strains isolated during
2008 to 2015. Resistance against polymixin B is reduced over the year (except
2014). Tetracycline resistance was also low until 2014. 1′, 2008; 2, 2009; 3,
2010; 4, 2011; 5, 2012; 6, 2013; 7, 2014; 8, 2015.







pathogens are mostly mobile in nature. Many antibiotic resistance
genes are physically linked with plasmids, integrative conjugative
elements (ICEs), and transposons. Comprehensive genomic
studies of all of the four isolates revealed several acquired genetic
elements in their genomes (Fig. 6). The physical linkage between
antibiotic resistance genes and plasmids, ICEs, and transpo-
sons was observed for both the XDR isolates IDH06781 and
IDH08148 (Fig. 6). XDR isolate IDH06781 harbors two large
plasmids, pVC1 (84.6 kb) and pVC2 (53.1 kb). pVC1 does not
carry any AMR genes, and most of the predicted ORFs are
hypothetical. For the plasmid pVC1, we could not find any DNA
sequence similarity (>3%) to the available DNA sequences in
the NCBI database. Several AMR genes, including bla, ant(3′),
and aac(3′), are physically linked with pVC2. pVC1 and pVC2
have lower GC content (∼40%) compared with the host chro-
mosome. Both plasmids encode several mobility functions (tra)
for their movement. In the plasmid-curing experiments, pVC2
was found to be essential for rifampicin, ciprofloxacin, tetracy-
cline, neomycin, and aztreonam resistance phenotypes in the
IDH06781 isolate (SI Appendix, Table S3). Curing of pVC1 had
no effect on the resistance phenotype of IDH06781 under lab-
oratory growth conditions (SI Appendix, Fig. S3). Similarly,
IDH08148 also harbored a large plasmid (∼94 kb) and encodes
β-lactamases, chloramphenicol acetyltransferase, aminoglycoside
3′-phosphotransferase, aminoglycoside N(3′) acetyltransferase,
and bleomycin resistance protein. Except for VCE232, all of the
three isolates harbor self-transmissible ICEs at the prfC locus of
Chr1. In addition, genomes of both the XDR isolates harbored
transposons (Tn3) and insertion sequences (IS6, IS30) and are
linked with AMR genes, including blaNDM-1, sh ble, aac(3′), and
ant(3′). Although all of the four isolates carry prophages like
CTXϕ in their genome, there is no physical linkage between the
phage genome and AMR genes.
Whole-Cell Proteome Analysis of XDR Isolate IDH06781 in the Presence
and Absence of Imipenem. Since the IDH06781 genome harbors the
maximum numbers of AMR genes, we used this isolate to inves-
tigate the whole-cell proteome profile in the presence and absence
of the broad-spectrum β-lactam antibiotic imipenem. A total of
2,270 proteins were identified using iTRAQ analysis. Differential
expression of 270 proteins was observed in the presence and ab-
sence of imipenem. Maximum repression (13.6-fold) was detected
for a glucose metabolic enzyme phosphoglucomutase that helps
interconversion of glucose 1-phosphate and glucose 6-phosphate.
Expression levels (∼2-fold) of cytochrome c oxidase and some
uncharacterized proteins were elevated in the presence of imi-
penem. We were able to detect expression of most of the AMR
proteins, including serine and metallo-β-lactamases, aminoglyco-
side acetyltransferase, aminoglycoside 3′-adenyltransferase, and
several other MDR proteins in the absence and presence of imi-
penem (Fig. 7). We did not find any significant difference in the
expression profile of AMR genes in the presence and absence of
imipenem. More importantly, we could detect high-level expression
of three different β-lactamases even in the absence of antibiotics.
This finding may suggest that β-lactamases contribute to additional
cellular functions other than only antimicrobial resistance.
Discussion
Antibiotic resistance is a serious global problem, and threatens
the efficacy of nearly all antibiotics commonly used to cure or
prevent microbial infections (11). Emergence of AMR is a nat-
ural phenomenon, and the resistance crisis has been expedited
due to the intensive usage of antibiotics in health sectors and
agriculture and the release of antibiotic-containing industrial
waste into the environment (14, 15). The antibiotic pressure al-
lows the selection of resistant variants and their proliferation and
spread to other biospheres. The susceptible population sharing
the same ecological niche with the resistant variants gets elimi-
nated in the presence of antibiotics. Resistance to multiple drugs
was first detected among enteric pathogens in the early 1960s
(16). In the last few decades, AMR V. cholerae has also evolved
rapidly and spread across the globe (17). Even during cholera
outbreak periods, chemoprophylaxis is not preferred, to avoid
the emergence of resistant pathogens. However, in clinical set-
tings, rehydration therapy and antibiotics are in use mainly to
reduce the duration of disease and volume of stools. During
the 1940s to 1960s, streptomycin, chloramphenicol, and tetra-
cycline were effectively used in the treatment of cholera (18).
Sulfamethoxazole-trimethoprim, azithromycin, and ciprofloxacin
were also used in the treatment of cholera during the 1970s (19).
Several classes of β-lactam antibiotics along with β-lactamase
inhibitors are also widely prescribed for acute gastritis. Over
the years, resistance in V. cholerae against all these antibiotics
turns out to be very high, and the resistance pattern directly
correlates with the usages of antibiotics (17).
Recent genomic studies on V. cholerae isolates had major
emphasis on the phylogenetic relationship between different
lineages and routes of transmission of cholera pathogens (17,
20). However, little is known about the resistance profile, traits
that confer resistance in V. cholerae, and mode of dissemination
of resistance traits between bacterial species. To understand the
emergence of resistant V. cholerae, it is important to identify the
mechanisms of resistance, genetic nature of resistance traits, and
Table 1. Relevant whole-genome sequencing information of different V. cholerae isolates
Characteristic IDH06781 VCE232 IDH08148 IDH0046
Year of isolation 2014 1980 2015 2001
Serogroup O96 O4 O1 Ogawa O139
Resistance phenotype R22 R3 R19 R7
Sequence size, Mb 924 796 874 954
No. of reads 535,245 637,875 1,237,893 1,337,254
Avg. read lengths, bp 767 355 707 714
No. of scaffolds 105 65 43 32
GC content, % 47.2 47.5 47.5 47.5
N50 92,624 160,909 235,586 636,425
Longest scaffold size, bp 452,388 318,788 572,897 796,078
Total no. of ORFs 4,294 3,636 3,608 3,624
ORFs encoding virulence, toxins, and AMR 117 89 89 82
Phage, Tn, plasmids 14 31 23 21
Table 2. Total number of ORFs (%) showing DNA sequence
similarity >90% between different V. cholerae isolates
Isolate IDH06781 VCE232 IDH08148 IDH0046
IDH06781 100 51.23 52.18 52.16
VCE232 59.75 100 88.23 87.53
IDH08148 61.02 88.40 100 93.82
IDH0046 60.60 87.75 93.21 100
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elements that contribute to the rapid dissemination of resistance.
Enteric pathogens are intrinsically resistant to very few antimi-
crobials; indeed, almost all of the resistance traits have been
acquired. The important factors that determine the probability
for bacterial populations to develop resistance against antibiotics
are (i) the frequency of exposure to antibiotics, (ii) the rate of
accumulation of point mutations in the target gene by sponta-
neous mutation, and (iii) the competency of acquiring resistance
functions from other organisms by HGT. V. cholerae is a natural
inhabitant of the aquatic environment, and the chances of ex-
posure to antibiotics are very high. In addition, the bacterium has
remarkable genetic plasticity that allows V. cholerae to respond
to a wide variety of environmental stresses, including antimi-
crobials (21). The bacterium is naturally competent and capable
of acquiring DNA from the environment by all of the three
major routes of HGT, namely transformation, conjugation, and
transduction. Analysis of the genomes of all of the four MDR
and XDR V. cholerae isolates revealed several genes involved in
somatic antigen biosynthesis, regulatory functions, nutrient and
metabolite transport, chemotaxis, DNA mobility, pathogenicity,
antibiotic and heavy-metal resistance is linked with MGEs
(Dataset S2). More than one dozen MGEs, including PIs, meta-
bolic islands, prophages, ICEs, transposons, insertion sequences,
and autonomously replicating and integrating plasmids are
identified in both XDR isolates IDH06781 and IDH08148. Most
of these acquired genetic elements encode tyrosine recombinase/
integrase for their mobility, and carry specific genomic signatures
that diverge from the core genome. In the XDR V. cholerae
IDH06781, nearly 5% of the genomic content is part of a flexible
gene pool. Currently, it is not clear the exact contribution of pVC1
to the physiology/fitness of IDH06781, since almost all of the
ORFs present in the plasmid are hypothetical in nature and the
curing of the plasmid from the XDR genome has no visible effect
on resistance phenotypes.
It is important to mention that the resistance traits are very
similar across the pathogens, and large numbers of AMR traits
are physically linked with MGEs. Whole-genome sequence anal-
ysis of the XDR V. cholerae isolates revealed the presence of
multiple resistance traits against each class of antimicrobial scaf-
fold (Fig. 5). β-Lactams are the most widely used broad-spectrum
antibiotics, and resistance to β-lactams is a serious threat for in-
fectious disease management, surgery, and organ transplantation.
Until now, more than 1,000 β-lactamases have been reported
(www.lahey.org/studies). The present study showed the presence
of several β-lactamase–encoding genes in both XDR isolates (Fig. 5).
Our functional analysis showed that the multiple resistance genes
present in the genome of XDR isolates are functionally active and
reflect the continuous evolution of bacterial species. Like β-lactamases,
multiple traits conferring resistance against aminoglycoside an-
tibiotics are also detected in the sequenced genomes of both the
XDR pathogens (Fig. 5). This correlates well with the overall
increase in aminoglycoside usage in clinical facilities in India for
many years (22). Finally, our whole-cell proteome analysis of
IDH06781 revealed that the multiple resistance genes present
in the genomes of XDR isolates are not only functionally active
but that most of them are constitutively expressed even in the
absence of antibiotics. This indicates the possibility of alternative
action of the resistance traits in the physiology of bacterial cells.
Conclusion
V. cholerae is an ancient human pathogen with extraordinary
genomic plasticity and capability to adapt to a changing envi-
ronment. In the last 10 years, more than 370 reports have been
published on the antimicrobial resistance of V. cholerae, but none
have comprehensive analysis of the prevalence of AMR traits,
diversity and abundance of resistance traits, and functionality of
predicted resistance genes and their expression in the presence
and absence of antibiotics. Our comprehensive analysis of 443
clinical V. cholerae isolates showed that the cholera pathogen is
continuously evolving to counterbalance the antimicrobial effects
of clinically important antibiotics. More importantly, the resis-
tance genes are physically linked with MGEs, and could poten-
tially propagate to other bacterial species through HGTs. To
combat the serious threat of rising AMR in enteric pathogens
and to prevent the decline in effectiveness of antibiotics of public
health importance, it is imperative to develop strategies for ro-
bust surveillance, restriction on improper antibiotic usage, and
identification of routes that are facilitating the rapid dissemi-
nation of antibiotic resistance in pathogenic and nonpathogenic
bacterial cells.
Fig. 5. Abundance of different antimicrobial resistance genes in the whole
genome-sequenced V. cholerae isolates. Size of the bubbles corresponds to
the abundance of resistance genes in the genomes of the four isolates.
Subclasses of the resistance genes are also mentioned within the bubble. The
picture was drawn to scale. Details of the resistance genes are provided in SI
Appendix.
Fig. 6. Mobile genetic elements linkedwith the antibiotic resistance genes in the
genome of V. cholerae. Mobile element proteins like transposase/integrase/site-
specific recombinase are used as signatures of MGEs. For β-lactamase, genes
A and D denote serine-β-lactamase, whereas B denotes metallo-β-lactamase.
Details of the resistance genes are provided in SI Appendix.








Bacterial Strains and Plasmids. V. cholerae were isolated on a thiosulfate-
citrate-bile salts-sucrose agar (Eiken) plate from the stool samples of acute
diarrheal patients. AMR profiles and relevant characteristics of the isolates are
provided in Dataset S1. Antibiotic susceptibility testing was performed using
BBL Sensi-Disc (BD), E-strip (bioMérieux), and broth dilution methods (SI Ap-
pendix). Sensitivity to each antibiotic was determined by evaluating the an-
nular radius of inhibition of growth around each disk in accordance with the
Clinical and Laboratory Standards Institute (CLSI-2016). As standard strains,
E. coli ATCC 25922 and V. cholerae O395 were used for all of the antibiotics.
Next-Generation DNA Sequencing. Genomic DNA was prepared by using the
cetyltrimethylammonium bromide method followed by RNase treatment.
Approximately 500 ng/μL DNA with no visible contamination of RNA or DNA
degradation was used for whole-genome sequencing (Roche). Details of the
sequencing are provided in SI Appendix.
Genome Assembly, Annotation, and Functional Analysis. A sequence assembly
tool, GS de novo genome assembler (Roche), was used to assemble quality
filtered sequencing reads. More than 90% identity and a minimum 40-nt
overlap were assigned to assemble the sequencing reads. Contigs and scaf-
folds were validated using the MegaBLAST program in the NCBI database.
Relevant information for all of the four genomes is provided in Table 1. The
translated protein sequences of the AMR genes were cross-compared with
the Comprehensive Antibiotic Resistance Database (https://card.mcmaster.ca/).
Cloning and Functional Validation of AMR Genes. All of the antibiotic re-
sistance genes with putative enzymatic functions were amplified from the
genome of the IDH06781 isolate and cloned under the control of the PBAD
promoter in pBD62 or pBAD24 expression vectors (SI Appendix, Table S2).
Primer sequences are available in SI Appendix, Table S4. Vectors were in-
troduced into E. coli by transformation. Resistance function was confirmed
in the presence of the desired antibiotics in the selection plate.
Plasmid Curing. Plasmid curing in XDR V. cholerae was done by growing V.
cholerae cells in elevated growth temperature at 42 °C. Details of plasmid
curing are provided in SI Appendix, Methods and Fig. S3.
Whole-Cell Proteome Analysis. Total protein extraction and trypsin digestion
weredone forwhole-cell proteomeanalysis ofXDR isolate IDH06781. Both control
and antibiotic-treated V. cholerae cells were used for proteome analysis.
Mass spectrometry analysis was performed using an LC system (Eksigent;
2D) coupled with a TripleTOF 5600 mass spectrometer (AB Sciex). Peptides
from each sample were labeled with isobaric tags (iTRAQ) in a four-plex set
(AB Sciex). MS/MS spectra were obtained in an information-dependent ac-
quisition mode with a TOF/MS survey scan (350 to 1,250 m/z). MS data were
analyzed by Protein Pilot 4.5 (AB Sciex) using the Paragon algorithm. Pro-
teins with a ratio >1.5 were considered to be differentially expressed. In all
cases, P < 0.05 (t test) was considered significant in protein quantification.
Statistical Analysis. Cross-comparison of resistance trends across different
groups was performed with Mann–Whitney U tests using the wilcox.test
function implemented in R programming package v3.0.0 (https://cran.r-project.
org/bin/windows/base/old/3.0.0/). Details are provided in SI Appendix.
Nucleotide Sequence Accession Number.Whole genome sequences are available
in the NCBI database under BioProject IDs PRJNA523098, PRJNA523099,
PRJNA523107, PRJNA523119 (23–26).
Ethical Clearance. Stool samples were collected from diarrheal patients ad-
mitted either to Maharishi Valmiki Infectious Diseases (MVID) Hospital, Delhi
(north India) or Infectious Diseases Hospital, Kolkata (east India) after obtaining
informed consent. Relevant approval was given by the institutional ethical
committees of MVID Hospital, Delhi (no. 1120/MS/MVIDH/2015) and National
Institute of Cholera and Enteric Diseases, Kolkata. All of the samples were
deidentified before use in this study.
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Fig. 7. Whole-cell proteome analysis revealed expression of different an-
timicrobial resistance genes in the presence and absence of antibiotic. The V.
cholerae IDH06781 strain was cultivated in the presence and absence of
imipenem. Whole-cell proteins were labeled using iTRAQ and detected by
TripleTOF 5600 mass spectrometer.
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